The American Society of Colon and Rectal Surgeons
(ASCRS) is dedicated to ensuring high-quality patient care by advancing the science, prevention, and
management of disorders and diseases of the colon, rectum,
and anus. The Clinical Practice Guidelines Committee is
composed of society members who are cho...
Seth, Rahul;
Agarwala, Sanjiv S;
Messersmith, Hans;
Alluri, Krishna C;
Ascierto, Paolo A;
Atkins, Michael B;
Bollin, Kathryn;
Chacon, Matias;
Davis, Nancy;
Faries, Mark B;
Funchain, Pauline;
Gold, Jason S;
Guild, Samantha;
Gyorki, David E;
Kaur, Varinder;
Khushalani, Nikhil I;
Kirkwood, John M;
McQuade, Jennifer Leigh;
Meyers, Michael O;
Provenzano, Anthony;
Robert, Caroline;
Santinami, Mario;
Sehdev, Amikar;
Sondak, Vernon K;
Spurrier, Gilliosa;
Swami, Umang;
Truong, Thach-Giao;
Tsai, Katy K;
van Akkooi, Alexander;
Weber, Jeffrey.
To provide guidance to clinicians regarding the use of systemic therapy for melanoma.
American Society of Clinical Oncology convened an Expert Panel and conducted an updated systematic review of the literature.
The updated review identified 21 additional randomized trials.
Neoadjuvant pembrolizumab was n...
This evaluation uses new cost-effectiveness estimates to update olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer (NICE technology appraisal guidance TA831). No new clinical evidence was reviewed. Treatments for BRCA mutation-positive hormone-relapsed meta...
Evidence-based recommendations on olaparib (Lynparza) for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer in adults.
Commercial arrangement
There is a simple discount patient access scheme for olaparib. NHS organisations can get details on the Commercial Access and ...
Evidence-based recommendations on mobocertinib (EXKIVITY) for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy in adults.
Commercial arrangement
There is a simple discount patient access scheme for mobocertinib. NHS organisations ca...
Elghazaly, Hesham;
Rugo, Hope;
Azim, Hamdy;
Swain, Sandra;
Arun, Banu;
Aapro, Matti;
Perez, Edith;
Anderson, Benjamin;
Penault-Llorca, Frederique;
Conte, Pierfranco.
The management of patients with triple-negative breast cancer (TNBC) is challenging with several controversies and unmet needs. During the 12th Breast-Gynaecological & Immuno-oncology International Cancer Conference (BGICC) Egypt, 2020, a panel of 35 breast cancer experts from 13 countries voted on conse...
Kim, Young Zoon;
Kim, Chae;
Wee, Chan Woo;
Hoon, Tae;
Hong, Je Beom;
Oh, Hyuk Jin;
Kang, Seok Gu;
Kang, Shin Hyuk;
Kong, Doo Sik;
Kim, Sung Hwan;
Kim, Se Hyuk;
Kim, Se Hoon;
Kim, Yu Jung;
Kim, Eui Hyun;
Kim, In Ah;
Ki, Ho Sung;
Park, Jae Sung;
Park, Hyun Jin;
Song, Sang Woo;
Sung, Kyoung Su;
Yang, Seung Ho;
Yoon, Wan Soon;
Yoon, Hong In;
Lee, Soon Tae;
Lee, Sea Won;
Lee, Youn Soo;
Lim, Jaejoon;
Chang, Jong Hee;
Jung, Tae Young;
Jung, Hye Lim;
Cho, Jae Ho;
Choi, Seung Hong;
Choi, Hyoung Soo;
Lim, Do Hoon;
Chung, Dong Sup.
There was no practical guideline for the management of patients with central nervous system tumor in Korea for many years. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, has developed the guideline for glioblastoma. Subsequently, the KSNO guideline for World Hea...
La Fibrosis Quística (FQ) es la enfermedad autosómica recesiva letal más frecuente en raza blanca. Se transmite de manera autosómica recesiva. Este patrón de herencia implica que una pareja de portadores tiene una probabilidad de 25% de tener un hijo con FQ en cada embarazo.
En Chile, de acuerdo con...
This document provides a summary of the evidence and recommendations for the use of SL-LPA for the detection of mutations associated with resistance to fluoroquinolones and SLID in patients with RR-TB and/or MDR-TB. The objectives of this policy guidance are to assess and compare the diagnostic accuracy ...
Tuberculose multirésistante/diagnostic,
Antibiotiques antituberculeux/pharmacologie,
Techniques de sonde moléculaire,
Tests de sensibilité microbienne,
Fluoroquinolones/usage thérapeutique,
Résistance bactérienne aux médicaments/génétique,
Génotype,
Mutation,
Tuberculose multirésistante/génétique,
Mycobacterium tuberculosis/effets des médicaments et des substances chimiques,
Mycobacterium tuberculosis/génétique
